| Mirabegron Combined With Behavioral Intervention for Overactive Bladder：a Prospective Multicenter Randomized Controlled Clinical Study (NCT05452434) | Peking Union Medical College Hospital | 2022-07-15 |
| Procedural Discomfort Related to Number of Intradetrusor Botox Injections (NCT05652036) | The Methodist Hospital Research Institute | 2022-07-07 |
| INvestigation of TENS Efficacy Versus Posterior Tibial Nerve Stimulation for Overactive Bladder (NCT05309993) | University of New Mexico | 2022-06-30 |
| Risk Factors for Treatment Failure in Women With Detrusor Overactivity Receiving Combined Pharmacotherapy (NCT07337252) | Mackay Memorial Hospital | 2022-06-01 |
| Evaluation of the Tensi+ Device for the Treatment of Overactive Bladder (NCT06847789) | Stimuli Technology | 2022-05-25 |
| A Study to Evaluate the Efficacy and Safety of DA-8010 in Patients With Overactive Bladder (NCT05282069) | Dong-A ST Co., Ltd. | 2022-05-12 |
| Intradetrusor Botulinum Toxin A for OAB Via 1 Versus 10 Injections: A Randomized Clinical Trial (NCT05308979) | University of California, Irvine | 2022-05-01 |
| A Sham-Controlled Study to Evaluate the Safety and Efficacy of a Smart, Self-Adjusting, Surgery-Free, Wearable Bladder Neuromodulation System for Overactive Bladder (NCT05381116) | Avation Medical, Inc. | 2022-04-14 |
| AURA 1: Augmenting Urinary Reflex Activity: Study 1 (NCT05256498) | Amber Therapeutics Ltd | 2022-04-01 |
| Acupuncture for Overactive Bladder in Adults (NCT05158361) | Guang'anmen Hospital of China Academy of Chinese Medical Sciences | 2022-03-08 |
| Evaluation of the TheraNova Neuromodulation System to Provide Durable Relief of Overactive Bladder Symptoms (NCT05162833) | Theranova, L.L.C. | 2022-02-20 |
| Beta 3 Agonists in Treatment of Non-neurogenic Voiding Dysfunction in Children (NCT05240456) | Mansoura University | 2022-02-01 |
| Pelvic Health Electrically Evoked Recording (PEER) 2 Study (NCT05200923) | MedtronicNeuro | 2022-01-18 |
| Botulinum Neurotoxin Type A (BoNT-A) in Paediatric Non-neurogenic Therapy Resistant Overactive Bladder (OAB) (NCT06569342) | University of Aarhus | 2022-01-15 |
| Comparing Number of Injection Sites of In-office Intravesical Onabotulinumtoxin A Treatments for Overactive Bladder: A Randomized Controlled Trial (NCT05157295) | Augusta University | 2022-01-01 |
| TEST-ON - Does iStim Reduce Urinary Urgency? (NCT04957524) | University of California, Los Angeles | 2021-12-20 |
| Sacral Neuromodulation in Neurogenic Patients (NCT05688644) | Omri Schwarztuch Gildor | 2021-12-19 |
| Acupuncture Combined With Mirabegron in the Treatment of OAB (NCT06181019) | The Affiliated Ganzhou Hospital of Nanchang University | 2021-12-01 |
| Efficacy And Safety Of Combination Therapy For Treatment Of Overactive Bladder In Male Patients With Benign Prostatic Hyperplasia. (NCT02279615) | St. Joseph's Healthcare Hamilton | 2021-12-01 |
| BTL Emsella Chair Versus Sham for the Treatment of Overactive Bladder (NCT04873037) | Corewell Health East | 2021-11-22 |
| Efficacy of Tadalafil/Solifenacin VS Tamsulosin/Solifenacin Combination Therapy for BPH/OAB (NCT05494567) | Mansoura University | 2021-11-08 |
| Composur: Study to Understand the Performance of Vibegron in Participants with Overactive Bladder (OAB) (NCT05067478) | Urovant Sciences GmbH | 2021-10-28 |
| Repetitive Transcranial Magnetic Stimulation in Women With Overactive Bladder With Urgency Incontinence (NCT05099419) | University of Southern California | 2021-10-28 |
| Evaluation of the TheraNova Neuromodulation System for the Treatment of Overactive Bladder Symptoms (NCT04758247) | Theranova, L.L.C. | 2021-10-28 |
| Posterior Tibial Nerve Stimulation (PTNS) Plus Mirabegron to Treat Refractory OAB Symptoms (PTNS-M Study) (NCT04907032) | University of Alabama at Birmingham | 2021-10-01 |
| Evaluation of the The Neuromodulation System for the Treatment of Overactive Bladder Symptoms (NCT04999657) | Medtecx Co Ltd. | 2021-08-26 |
| Effects of Transcutaneous Tibial Nerve Stimulation for Overactive Bladder Symptoms in Adults (NCT05464589) | Dow University of Health Sciences | 2021-08-10 |
| The Effects of Pelvic Floor Muscle Training in Women With Overactive Bladdder (NCT04950556) | Ataturk Training and Research Hospital | 2021-07-01 |
| Overactive Bladder Telemedicine Non-inferiority Trial (NCT05117918) | University of California, Los Angeles | 2021-07-01 |
| Strong Desire to Void and Balance in Older Women With Overactive Bladder (NCT04910555) | Assistance Publique - Hôpitaux de Paris | 2021-05-26 |
| Evaluation of Implantable Tibial Neuromodulation (TITAN 1) Feasibility Study (NCT04873271) | MedtronicNeuro | 2021-05-11 |
| Impact of OAB Symptoms on Quality of Life in Croatia (NCT04865328) | University of Zagreb | 2021-05-10 |
| Antibiotic Usage Prior to OnabotulinumtoxinA Injection (NCT04754737) | Benaroya Research Institute | 2021-03-23 |
| FREEOAB Study for Overactive Bladder (NCT04547920) | Avation Medical, Inc. | 2021-01-11 |
| Evaluation of Silodosin and Pelvic Floor Muscle Training in Men With Benign Prostatic Hyperplasia and Overactive Bladder (NCT04681625) | Comenius University | 2021-01-11 |
| The Urinary Microbiome in Patients Receiving Intradetrusor Botox Injections (NCT04479709) | MetroHealth Medical Center | 2021-01-01 |
| Nerve Stimulation Using a TENS to Provide Pain Relief During Surgery for Overactive Bladder (NCT05330117) | University of Rochester | 2020-12-14 |
| TENS Used for Pain Management During Office Cystoscopy Botox Injections (NCT04448171) | Mayo Clinic | 2020-10-28 |
| Clinical Study to Evaluate the Treatment Effect and Safety of BAY1817080 in Patients With Overactive Bladder (OAB) (NCT04545580) | Bayer | 2020-09-16 |
| Transcutaneous Tibial Nerve Stimulation: the ZIDA Device Equivalence (NCT04470765) | Exodus Innovations | 2020-09-15 |
| "The Effectiveness of Transvertebral Magnetic Neuromodulation in Patients With Detrusor Overactivity" (NCT04578899) | Joint-Stock Company North-West Center for Evidence-Based Medicine, Russian Federation | 2020-09-04 |
| InterStim Micro Post Market Clinical Follow-up Study (ELITE) (NCT04506866) | MedtronicNeuro | 2020-08-25 |
| BE Technologies Mobile Uroflowmetry Validation Study (NCT04599283) | BE Technologies Inc | 2020-08-18 |
| Minimizing Pain During Office Intradetrussor Botox Injection (NCT04270526) | Boston Urogynecology Associates | 2020-08-15 |
| Study on the Safety of BAY1817080 How it is Tolerated and the Way the Body Absorbs, Distributes and Gets Rid of the Study Drug Given to Participants With Moderate Renal Impairment and End Stage Renal Disease Requiring Dialysis Compared With Matched Participants With Normal Renal Function (NCT04471337) | Bayer | 2020-08-12 |
| A Trial to Learn How a New Liquid Form of BAY1817080 is Tolerated and Taken up by the Body of Healthy Male Participants (Part A). By Labeling BAY1817080 With a Radioactive Substance (Carbon 14) Researchers Want to Learn How the Study Drug is Processed and Excreted by the Body After Dosing (Part B) (NCT04487431) | Bayer | 2020-08-05 |
| Study on the Safety of BAY1817080, How it is Tolerated and the Way the Body Absorbs, Distributes and Gets Rid of the Study Drug in Participants With Impaired Liver Function or Normal Liver Function (NCT04454424) | Bayer | 2020-07-23 |
| A Study to Evaluate Drug-drug Interactions Between BR9006-1 and BR9006-2 in Healthy Male Volunteers. (NCT04485585) | Boryung Pharmaceutical Co., Ltd | 2020-07-20 |
| Efficacy of Li-SWT on Persistent Storage Symptoms After Transurethral Surgery for BPO (NCT04437108) | Mansoura University | 2020-07-04 |
| Study to Gather Information on the Influence of BAY1817080 on the Electrical Activity of the Heart Recorded by an Electrocardiogram in Healthy Male and Female Participants (NCT04423744) | Bayer | 2020-06-18 |
| What is the Effect of Prolapse Surgery on Voiding? (NCT04429360) | Universiteit Antwerpen | 2020-06-08 |
| Tolterodine Relieves Overactive Bladder Symptoms in Women With Moderate-to-severe Obstructive Sleep Apnea Syndrome (NCT05250245) | Yuzuncu Yil University | 2020-06-01 |
| To Evaluate the Efficacy and Safety of JLP-2002 on Symptoms of Overactive Bladder (NCT04917315) | Jeil Pharmaceutical Co., Ltd. | 2020-05-21 |
| Evaluate the Safety and Efficacy of Botulax® Versus Botox® in Patient With Overactive Bladder (NCT04186442) | Hugel | 2020-05-12 |
| NOGO for an Overactive Bladder (NCT04357223) | SagaNatura | 2020-05-01 |
| Effects of Low-intensity Excoporeal Shock Wave Therapy (LiESWT) on Women With Pelvic Floor Dysfunction (NCT05337813) | Kaohsiung Medical University Chung-Ho Memorial Hospital | 2020-04-10 |
| Noninvasive Spinal Cord Stimulation for Neurogenic and Idiopathic Overactive Bladder (NCT03753750) | University of Southern California | 2020-03-24 |
| Effectiveness of EMS and TENS in Patients With Overactive Bladder (NCT04364438) | Isra University | 2020-03-03 |
| Study on the Safety of Drug BAY1817080 at Different Doses and the Way the Body Absorbs and Eliminates the Drug in Japanese Healthy Adult Male Participants (NCT04265781) | Bayer | 2020-02-15 |
| High Intensity Focused Electromagnetic Field Device for Urinary Incontinence (NCT04031014) | Boston Urogynecology Associates | 2020-02-01 |
| AQUA: Anticholinergic Side Effects QUestionnAire (NCT04791111) | Pierre and Marie Curie University | 2020-01-01 |
| Comparison of Different Treatments for Overactive Bladder Syndrome (NCT04197466) | Ankara Yildirim Beyazıt University | 2019-12-06 |
| InterStim Basic Evaluation Lead Post-Market Clinical Follow-up Study (NCT04016324) | MedtronicNeuro | 2019-11-28 |
| Is 10 Injections of Bladder Botox Less Painful Than 20 Injections? (NCT04124939) | Wake Forest University Health Sciences | 2019-11-10 |
| In-office Assessment of Voiding Function Following Botox Injection for Overactive Bladder (NCT04155593) | TriHealth Inc. | 2019-11-08 |
| Effectiveness of Microcurrents Therapy in Overactive Bladder. (NCT04120545) | University of Las Palmas de Gran Canaria | 2019-11-04 |
| Extracorporeal Magnetic Innervation in Combination With Mirabegron in the Treatment of Overactive Bladder (NCT06123364) | Serdinsek Tamara | 2019-10-14 |
| Extension Study of Vibegron in Men With Overactive Bladder (OAB) Symptoms on Pharmacological Therapy for Benign Prostatic Hyperplasia (NCT04103450) | Urovant Sciences GmbH | 2019-09-19 |
| Clinical Trial to Evaluate the Efficacy and Safety of MEDITOXIN® in Subject With Idiopathic Overactive Bladder (NCT04113941) | Medy-Tox | 2019-08-23 |
| Higher Neural Changes Following Anticholinergic, Beta 3 Agonist, or Placebo in Patients With Overactive Bladder (NCT03817931) | Baylor Research Institute | 2019-08-05 |
| Red Clover Isoflavones in Postmenopausal Women With Urge Urinary Incontinence and Overactive Bladder (NCT05013593) | Regionshospital Nordjylland | 2019-07-15 |
| Standard Injections Versus Reduced Injections for Intravesical onabotulinumtoxinA Treatment of Overactive Bladder (NCT04020510) | Walter Reed National Military Medical Center | 2019-07-01 |
| Transvaginal Botulinum Toxin A Chemodenervation for Overactive Bladder (NCT05463822) | Stanford University | 2019-06-20 |
| ADRB3, ROCK2 and GEF Levels in Overactive Bladder Patients (NCT04626960) | Pamukkale University | 2019-06-05 |
| Optimizing Overactive Bladder Treatment (NCT03904407) | University of North Carolina, Chapel Hill | 2019-06-01 |
| The Treatment Efficacy of Prolotherapy in Bladder Voiding Dysfunction (NCT05485142) | Taichung Armed Forces General Hospital | 2019-05-01 |
| Feasibility of Parasacral Transcutaneous Electrical Nerve Stimulation PTENS for Voiding Dysfunction in Peds Population (NCT04570605) | University of Utah | 2019-04-01 |
| Study to Evaluate the Efficacy, Safety and Tolerability of Vibegron in Men With Overactive Bladder (OAB) Symptoms on Pharmacological Therapy for Benign Prostatic Hyperplasia (BPH) (NCT03902080) | Urovant Sciences GmbH | 2019-03-26 |
| eCoin for OAB Feasibility Follow-on Study (NCT03655054) | Valencia Technologies Corporation | 2019-03-13 |
| PTNS on Urinary and Global Quality of Life in MS Patients (NCT04063852) | University of Michigan | 2019-02-27 |
| Impact of Decision Aids in Urogynecology (NCT04369404) | Massachusetts General Hospital | 2019-02-01 |
| Arabic Translation and Validation of the (Overactive Bladder Symptom Score) OABSS (NCT04309890) | Mutah University | 2019-02-01 |
| Vibe First In Human Study for the Assessment of Safety and Initial Performance of the Vibe Delivery System in Subjects With Idiopathic Overactive Bladder (NCT03874780) | Vensica Therapeutics Ltd. | 2019-01-29 |
| The Clinical Effects of Laser Acupuncture Therapy for OAB Women. (NCT03829137) | Chang Gung Memorial Hospital | 2019-01-01 |
| Group Medical Visits for Latina Women With Urgency Urinary Incontinence (NCT03687164) | University of Southern California | 2018-11-01 |
| Posterior Tibial Nerve Stimulation's Effectiveness in UI Frequency in Overactive Patients in Home (NCT03595215) | Theranova, L.L.C. | 2018-09-10 |
| Pivotal Study of eCoin for Overactive Bladder With Urgency Urinary Incontinence (NCT03556891) | Valencia Technologies Corporation | 2018-09-04 |
| TPTNS: Home vs Hospital Treatment for Overactive Bladder (NCT03727711) | NHS Greater Glasgow and Clyde | 2018-09-03 |
| Evaluation of Intradetrusor AbobotulinumtoxinA and IncobotulinumtoxinA in Women With Overactive Bladder (NCT06250543) | Niko Kavcic | 2018-08-14 |
| OnabotulinumtoxinA Bladder Injection Study (NCT03523091) | Corewell Health East | 2018-08-08 |
| Fluids Affecting Bladder Urgency and Lower Urinary Symptoms (NCT03625492) | University of Michigan | 2018-08-07 |
| Experience Sampling Method in OAB Patients (NCT03435991) | Maastricht University Medical Center | 2018-08-06 |
| Use of Biotene Moisturizing Mouth Spray for Xerostomia Associated With Oral Oxybutynin Use (NCT02522936) | University of Southern California | 2018-08-01 |
| A Study to Evaluate Once Daily Low Dose and High Dose Solabegron or Placebo Given for 12 Weeks to Treat Women With Symptoms of Overactive Bladder: Sudden Urge to Urinate, Frequent Urination Associated With Wetting Episodes (VEL-2001) (NCT03594058) | Velicept Therapeutics, Inc. | 2018-07-09 |
| Comparison of Methods for Prevention of Urinary Tract Infection Following Botox Injection (NCT03508921) | Vanderbilt University Medical Center | 2018-07-01 |
| An Extension Study to Examine the Safety and Tolerability of a New Drug in Patients With Symptoms of Overactive Bladder (OAB). (NCT03583372) | Urovant Sciences GmbH | 2018-06-14 |
| Effects of Connective Tissue Massage in Women With Overactive Bladder (NCT03695692) | Seyda TOPRAK CELENAY | 2018-05-02 |
| A Study to Examine the Safety and Efficacy of a New Drug in Patients With Symptoms of Overactive Bladder (OAB) (NCT03492281) | Urovant Sciences GmbH | 2018-03-26 |
| Sham Controlled Trial of Rapid Induction Percutaneous Tibial Nerve Stimulation (NCT03547518) | Corewell Health East | 2018-03-13 |
| Efficacy and Safety of Electroacupuncture and Acupuncture in Postmenopausal Women With Overactive Bladder (NCT03260907) | DongGuk University | 2018-03-02 |